Effect of anticholinergic drugs on cognitive impairment in the elderly;Efecto de los fármacos anticolinérgicos en el rendimiento cognitivo de las personas mayores

Revista de Psiquiatria y Salud Mental

Volumn 8, Issue 1, 2015, Pages 35-43

  López Álvarez, Jorge ^a   Zea Sevilla, María Ascensión ^a   Agüera Ortiz, Luis ^a,b   Fernández Blázquez, Miguel Ángel ^a   Valentí Soler, Meritxell ^a   Martínez Martín, Pablo ^a,c  

^a Instituto de Salud Carlos III   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE SALUD MENTAL CIBERSAM   (Spain)

^c CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

Author keywords

Alzheimers disease; Dementia; Mild cognitive impairment; Serum anticholinergic activity

Indexed keywords

CHOLINERGIC RECEPTOR BLOCKING AGENT; CHOLINESTERASE INHIBITOR; APOLIPOPROTEIN E4; MUSCARINIC RECEPTOR;

AGED; COGNITIVE DEFECT; DRUG BLOOD LEVEL; HUMAN; REVIEW; SYSTEMATIC REVIEW; CHEMICALLY INDUCED; COGNITION DISORDERS; COMORBIDITY; CROSS-SECTIONAL STUDY; DIAGNOSTIC ERROR; DRUG EFFECTS; DRUG UTILIZATION; FEMALE; GENETIC PREDISPOSITION; GENETICS; MALE; PHYSIOLOGY; POLYPHARMACY; PREVALENCE; RETROSPECTIVE STUDY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; APOLIPOPROTEIN E4; CHOLINERGIC ANTAGONISTS; CHOLINESTERASE INHIBITORS; COGNITION DISORDERS; COMORBIDITY; CROSS-SECTIONAL STUDIES; DIAGNOSTIC ERRORS; DRUG UTILIZATION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; POLYPHARMACY; PREVALENCE; RECEPTORS, MUSCARINIC; RETROSPECTIVE STUDIES;

EID: 84925682829     PISSN: 18889891     EISSN: 19894600     Source Type: Journal    
DOI: 10.1016/j.rpsm.2013.11.003     Document Type: Short Survey

References (49)

1. G. Potamianos, and J.M. Kellet Anti-cholinergic drugs and memory: The effects of benzhexol on memory in a group of geriatric patients Br J Psychiatry 140 1982 470 472
2. L.E. Tune Anticholinergic effects of medication in elderly patients J Clin Psychiatry 62 Suppl 21 2001 11 14
3. N. Lechevallier-Michel, M. Molimard, J.F. Dartigues, C. Fabrigoule, and A. Fourrier-Réglat Drugs with anticholinergic properties and cognitive performance in the elderly: Results from the PAQUID Study Br J Clin Pharmacol 59 2005 143 151
4. C.M. Roe, M.J. Anderson, and B. Spivack Use of anticholinergic medications by older adults with dementia J Am Geriatr Soc 50 2002 836 842
5. B.E. Harrison, and B. Therrien Effect of antipsychotic medication use on memory in patients with Alzheimer's disease: Assessing the potential risk for accelerated recent autobiographical memory loss J Gerontol Nurs 33 2007 11 20
6. R.T. Bartus, R.L. Dean 3rd, B. Beer, and A.S. Lippa The cholinergic hypothesis of geriatric memory dysfunction Science 217 1982 408 414
7. K.A. Bottiggi, J.C. Salazar, L. Yu, A.M. Caban-Holt, M. Ryan, and M.S. Mendionde Long-term cognitive impact of anticholinergic medications in older adults Am J Geriatr Psychiatry 14 2006 980 984
8. A.R. Moore, and S.T. O'Keeffe Drug-induced cognitive impairment in the elderly Drugs Aging 15 1999 15 28
9. M.L. Catterson, S.H. Preskorn, and R.L. Martin Pharmacodynamic and pharmacokinetic considerations in geriatric psychopharmacology Psychiatr Clin North Am 20 1997 205 218
10. C.J. Lu, and L.E. Tune Chronic exposure to anticholinergic medications adversely affects the course of Alzheimer disease Am J Geriatr Psychiatry 11 2003 458 461
11. R.M. Carnahan, B.C. Lund, P.J. Perry, and E.A. Chrischilles The concurrent use of anticholinergics and cholinesterase inhibitors: Rare event or common practice? J Am Geriatr Soc 52 2004 2082 2087
12. K.H. Pitkala, T.E. Strandberg, and R.S. Tilvis Inappropriate drug prescribing in home-dwelling, elderly patients: A population-based survey Arch Intern Med 162 2002 1707 1712
13. N. Campbell, M. Boustani, T. Limbil, C. Ott, C. Fox, and I. Maidment The cognitive impact of anticholinergics. A clinical review Clin Interv Aging 4 2009 225 233
14. F. Jessen, H. Kaduszkiewicz, M. Daerr, H. Bickel, M. Pentzek, and S. Riedel-Heller Anticholinergic drug use and risk for dementia: Target for dementia prevention Eur Arch Psychiatry Clin Neurosci 260 Suppl 2 2010 S111 S115
15. M.L. Chew, B.H. Mulsant, B.G. Pollock, M.E. Lehman, A. Greenspan, and R.A. Mahmoud Anticholinergic activity of 107 medications commonly used by older adults J Am Geriatr Soc 56 2008 1333 1341
16. K. Hori, K. Konishi, K. Watanabe, H. Uchida, T. Tsuboi, and M. Moriyasu Influence of anticholinergic activity in serum on clinical symptoms of Alzheimer's disease Neuropsychobiology 63 2011 147 153
17. K. Plaschke, J. Kopitz, J. Mattern, E. Martin, and P. Teschendorf Increased cortisol levels and anticholinergic activity in cognitively unimpaired patients J Neuropsychiatry Clin Neurosci 22 2010 433 441
18. C. Fox, G. Livingston, I.D. Maidment, S. Coulton, D.G. Smithard, and M. Boustani The impact of anticholinergic burden in Alzheimer's dementia-the LASER-AD study Age Ageing 40 2011 730 735
19. C. Thomas, U. Hestermann, J. Kopitz, K. Plaschke, P. Oster, and M. Driessen Serum anticholinergic activity and cerebral cholinergic dysfunction: An EEG study in frail elderly with and without delirium BMC Neurosci 9 2008 86
20. M. Wawruch, A. Macugova, L. Kostkova, J. Luha, A. Dukat, and J. Murin The use of medications with anticholinergic properties and risk factors for their use in hospitalised elderly patients Pharmacoepidemiol Drug Saf 21 2012 170 176
21. R.M. Carnahan, B.C. Lund, P.J. Perry, B.G. Pollock, and K.R. Culp The Anticholinergic Drug Scale as a measure of drug-related anticholinergic burden: Associations with serum anticholinergic activity J Clin Pharmacol 46 2006 1481 1486
22. J.L. Rudolph, M.J. Salow, M.C. Angelini, and R.E. McGlinchey The anticholinergic risk scale and anticholinergic adverse effects in older persons Arch Intern Med 168 2008 508 513
23. S.N. Hilmer, D.E. Mager, E.M. Simonsick, Y. Cao, S.M. Ling, and B.G. Windham A drug burden index to define the functional burden of medications in older people Arch Intern Med 167 2007 781 787
24. S.N. Hilmer, D.E. Mager, E.M. Simonsick, S.M. Sing, B.G. Windham, and T.B. Harris Drug burden index score and functional decline in older people Am J Med 122 2009 1142 1149
25. L. Tune, S. Carr, E. Hoag, and T. Cooper Anticholinergic effects of drugs commonly prescribed for the elderly: Potential means for assessing risk of delirium Am J Psychiatry 149 1992 1393 1394
26. F. García-Gollarte, J. Baleriola-Júlvez, I. Ferrero-López, and A.J. Cruz-Jentoft Inappropriate drug prescription at nursing home admission J Am Med Dir Assoc 13 2012 83.e9-15
27. D.G. Blazer 2nd, C.F. Federspiel, W.A. Ray, and W. Schaffner The risk of anticholinergic toxicity in the elderly: A study of prescribing practices in two populations J Gerontol 38 1983 31 35
28. S. Chatterjee, S. Mehta, J.T. Sherer, and R.R. Aparasu Prevalence and predictors of anticholinergic medication use in elderly nursing home residents with dementia: Analysis of data from the 2004 National Nursing Home Survey Drugs Aging 27 2010 987 997
29. R. Bhattacharya, S. Chatterjee, R.M. Carnahan, and R.R. Aparasu Prevalence and predictors of anticholinergic agents in elderly outpatients with dementia Am J Geriatr Pharmacother 9 2011 434 441
30. M. Robinson, D. Rowett, A. Leverton, and V. Mabbott Changes in utilization of anticholinergic drugs after initiation of cholinesterase inhibitors Pharmacoepidemiol Drug Saf 18 2009 659 664
31. T.J. Crow, and I.G. Grove-White An analysis of the learning deficit following hyoscine administration to man Br J Pharmacol 49 1973 322 327
32. B.R. Nakra, R.B. Margolis, J.D. Gfeller, G.T. Grossberg, and L.S. Sata The effect of a single low dose of trihexyphenidyl on memory functioning in the healthy elderly Int Psychogeriatr 4 1992 207 214
33. D. Gnjidic, D.G. le Couteur, V. Naganathan, R.G. Cumming, H. Creasey, and L.M. Waite Effects of drug burden index on cognitive function in older men J Clin Psychopharmacol 32 2012 273 277
34. M.P. Fortin, I. Rouch, V. Dauphinot, C. Gédéon, S. Genthon, and M. Bonnefoy Effects of anticholinergic drugs on verbal episodic memory function in the elderly: A retrospective, cross-sectional study Drugs Aging 28 2011 195 204
35. B.W. Rovner, A. David, M.J. Lucas-Blaustein, B. Conklin, L. Filipp, and L. Tune Self-care capacity and anticholinergic drug levels in nursing home patients Am J Psychiatry 145 1988 107 109
36. K. Konishi, K. Hori, H. Uchida, K. Watanabe, I. Tominaga, and M. Kimura Adverse effects of anticholinergic activity on cognitive functions in Alzheimer's disease Psychogeriatrics 10 2010 34 38
37. G. Sittironnarit, D. Ames, A.I. Bush, N. Faux, L. Flicker, and J. Foster Effect of anticholinergic drugs on cognitive function in older Australians: Results from the AIBL study Dement Geriatr Cogn Disord 31 2011 173 178
38. M.L. Chew, B.H. Mulsant, and B.G. Pollock Serum anticholinergic activity and cognition in patients with moderate-to-severe dementia Am J Geriatr Psychiatry 13 2005 535 538
39. B.H. Mulsant, B.G. Pollock, M. Kirshner, C. Shen, H. Dodge, and M. Ganguli Serum anticholinergic activity in a community-based sample of older adults: Relationship with cognitive performance Arch Gen Psychiatry 60 2003 198 203
40. M.L. Ancelin, S. Artero, F. Portet, A.M. Dupuy, J. Touchon, and K. Ritchie Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: Longitudinal cohort study BMJ 332 2006 455 459
41. I. Carrière, A. Fourrier-Reglat, J.F. Dartigues, O. Rouaud, F. Pasquier, and K. Ritchie Drugs with anticholinergic properties, cognitive decline, and dementia in an elderly general population: The 3-City Study Arch Intern Med 169 2009 1317 1324
42. L.J. Whalley, S. Sharma, H.C. Fox, A.D. Murray, R.T. Staff, and A.C. Duthie Anticholinergic drugs in late life: Adverse effects on cognition but not on progress to dementia J Alzheimers Dis 30 2012 253 261
43. L. Han, J.V. Agostini, and H.G. Allore Cumulative anticholinergic exposure is associated with poor memory and executive function in older men J Am Geriatr Soc 56 2008 2203 2210
44. C. Fox, K. Richardson, I.D. Maidment, G.M. Savva, F.E. Matthews, and D. Smithard Anticholinergic medication use and cognitive impairment in the older population: The medical research council cognitive function and ageing study J Am Geriatr Soc 59 2011 1477 1483
45. J. Uusvaara, K.H. Pitkala, P.J. Tienari, H. Kautiainen, R.S. Tilvis, and T.E. Strandberg Association between anticholinergic drugs and apolipoprotein E epsilon 4 allele and poorer cognitive function in older cardiovascular patients: A cross-sectional study J Am Geriatr Soc 57 2009 427 431
46. N. Pomara, L.M. Willoughby, K. Wesnes, and J.J. Sidtis Increased anticholinergic challenge-induced memory impairment associated with the APOE-epsilon4 allele in the elderly: A controlled pilot study Neuropsychopharmacology 29 2004 403 409
47. D.M. Boudreau, O. Yu, S.L. Gray, M.A. Raebel, J. Johnson, and E.B. Larson Concomitant use of cholinesterase inhibitors and anticholinergics: Prevalence and outcomes J Am Geriatr Soc 59 2011 2069 2076
48. K.A. Bottiggi, J.C. Salazar, L. Yu, A.M. Caban-Holt, M. Ryan, and F.A. Schmitt Concomitant use of medications with anticholinergic properties and acetylcholinesterase inhibitors: Impact on cognitive and physical functioning in Alzheimer disease Am J Geriatr Psychiatry 15 2007 357 359
49. E. Jedenius, K. Johnell, J. Fastborn, J. Strömqvist, B. Winblad, and N. Andreasen Dementia management programme in a community setting and the use of psychotropic drugs in the elderly population Scand J Prim Health Care 29 2011 181 186